Looking to publish in Expert Opinion on Biological Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginExpert Opinion on Biological Therapy is a MEDLINE-indexed international hybrid journal focused on biological therapy, including gene therapy, gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, cell-based therapies, stem cell therapies, and tissue-based therapies. It publishes rigorously peer-reviewed review articles and original papers, uses double-anonymous peer review after editorial suitability assessment, and does not publish case reports or case series.
Looking to publish in Expert Opinion on Biological Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Expert Opinion on Biological Therapy is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Review Articles
Original Research
Drug Evaluation
Clinical Trial Evaluation
Letter To The Editor
Recent Publications
Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP)
Francesco Menzella, Eugenio De Corso, Marco Caminati, Walter Cestaro, Laura Ventura, Paolo Cameli, Sara Munari, Umberto Semenzato, Rory Chan, Alvise Berti, Angelo Ghidini, Paolo Russo, Isabella Ruzzon, Alessio De Massimi, Maria Rita Marchi, Carlo Lombardi, Michela Bortoli, Claudia Rinaldo, Riccardo Pozzan, Fabio Giuseppe Vassallo, Francesco Gialdini, Tatiana Scandiuzzi Piovesan, Marcello Cottini, Gianenrico Senna, Lorenzo Corsi, Antonio Romano, Andrea Tozzi, Giancarlo Ottaviano
Breaking immune exclusion in cold tumors via TGF-β pathway inhibition
Minjun Zhang, Yuchen Sun, Luyan Chen, Dixuan Xue, Di Zhang, Ming Yi, Zhijun Dai
Sequencing and switching among IL-17 and IL-23 biologics in plaque psoriasis: real-world lessons and precision strategies for the future
Clarissa Fava, Edoardo Zompanti, Eleonora De Luca, Clara De Simone, Ketty Peris, Giacomo Caldarola
Anakinra treatment practices in colchicine-resistant familial Mediterranean fever: a survey of pediatric rheumatologists conducted through the PReS AID-WP and the Turkish pediatric rheumatology associations
Sıla Atamyıldız Uçar, Eray Tunce, Betül Sözeri
Targeting autoimmune pulmonary alveolar proteinosis with GM-CSF: insights from clinical trials and emerging therapies
Margaret Higgins, Niamh Boyle, Cormac McCarthy
Frequently asked questions
How long does it take to publish?
Accepted Author Version is published online in 3 days if the copyright form has been received. Accelerated Publication Plus offers a final decision in as little as 3 weeks, with online publication usually 1-2 weeks after acceptance and first proofs within 5 working days. Accelerated Publication offers a final decision in as little as 9 weeks, with online publication usually 2-3 weeks after acceptance and first proofs within 5 working days.
Reformat to Expert Opinion on Biological Therapy using Livewrite PremiumIs a cover letter required?
A covering letter is required. It must include corresponding author contact details, statements of originality and exclusive submission, confirmation that all authors approved the manuscript and ICMJE conditions were met, ethical approval information, and disclosure of financial or other relationships. Manuscripts without a covering letter or a Disclosure Form are not considered complete submissions.
Reformat to Expert Opinion on Biological Therapy using Livewrite PremiumWhat are the publication costs?
Institutional online-only subscription: USD 9,716.00; institutional print and online subscription: USD 14,201.00.
Reformat to Expert Opinion on Biological Therapy using Livewrite Premium